Table of Content

1 Study Coverage
1.1 Pharma Sustained Release Excipient Product Introduction
1.2 Market by Type
1.2.1 Global Pharma Sustained Release Excipient Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Gelatin
1.2.3 Polymers
1.2.4 Minerals
1.2.5 Sugars
1.2.6 Chitosan
1.3 Market by Application
1.3.1 Global Pharma Sustained Release Excipient Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical
1.3.3 Health Care
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharma Sustained Release Excipient Sales Estimates and Forecasts 2018-2029
2.2 Global Pharma Sustained Release Excipient Revenue by Region
2.2.1 Global Pharma Sustained Release Excipient Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Pharma Sustained Release Excipient Revenue by Region (2018-2024)
2.2.3 Global Pharma Sustained Release Excipient Revenue by Region (2024-2029)
2.2.4 Global Pharma Sustained Release Excipient Revenue Market Share by Region (2018-2029)
2.3 Global Pharma Sustained Release Excipient Sales Estimates and Forecasts 2018-2029
2.4 Global Pharma Sustained Release Excipient Sales by Region
2.4.1 Global Pharma Sustained Release Excipient Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Pharma Sustained Release Excipient Sales by Region (2018-2024)
2.4.3 Global Pharma Sustained Release Excipient Sales by Region (2024-2029)
2.4.4 Global Pharma Sustained Release Excipient Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pharma Sustained Release Excipient Sales by Manufacturers
3.1.1 Global Pharma Sustained Release Excipient Sales by Manufacturers (2018-2024)
3.1.2 Global Pharma Sustained Release Excipient Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pharma Sustained Release Excipient in 2022
3.2 Global Pharma Sustained Release Excipient Revenue by Manufacturers
3.2.1 Global Pharma Sustained Release Excipient Revenue by Manufacturers (2018-2024)
3.2.2 Global Pharma Sustained Release Excipient Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pharma Sustained Release Excipient Revenue in 2022
3.3 Global Key Players of Pharma Sustained Release Excipient, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Pharma Sustained Release Excipient Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pharma Sustained Release Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pharma Sustained Release Excipient, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pharma Sustained Release Excipient, Product Offered and Application
3.8 Global Key Manufacturers of Pharma Sustained Release Excipient, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pharma Sustained Release Excipient Sales by Type
4.1.1 Global Pharma Sustained Release Excipient Historical Sales by Type (2018-2024)
4.1.2 Global Pharma Sustained Release Excipient Forecasted Sales by Type (2024-2029)
4.1.3 Global Pharma Sustained Release Excipient Sales Market Share by Type (2018-2029)
4.2 Global Pharma Sustained Release Excipient Revenue by Type
4.2.1 Global Pharma Sustained Release Excipient Historical Revenue by Type (2018-2024)
4.2.2 Global Pharma Sustained Release Excipient Forecasted Revenue by Type (2024-2029)
4.2.3 Global Pharma Sustained Release Excipient Revenue Market Share by Type (2018-2029)
4.3 Global Pharma Sustained Release Excipient Price by Type
4.3.1 Global Pharma Sustained Release Excipient Price by Type (2018-2024)
4.3.2 Global Pharma Sustained Release Excipient Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Pharma Sustained Release Excipient Sales by Application
5.1.1 Global Pharma Sustained Release Excipient Historical Sales by Application (2018-2024)
5.1.2 Global Pharma Sustained Release Excipient Forecasted Sales by Application (2024-2029)
5.1.3 Global Pharma Sustained Release Excipient Sales Market Share by Application (2018-2029)
5.2 Global Pharma Sustained Release Excipient Revenue by Application
5.2.1 Global Pharma Sustained Release Excipient Historical Revenue by Application (2018-2024)
5.2.2 Global Pharma Sustained Release Excipient Forecasted Revenue by Application (2024-2029)
5.2.3 Global Pharma Sustained Release Excipient Revenue Market Share by Application (2018-2029)
5.3 Global Pharma Sustained Release Excipient Price by Application
5.3.1 Global Pharma Sustained Release Excipient Price by Application (2018-2024)
5.3.2 Global Pharma Sustained Release Excipient Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Pharma Sustained Release Excipient Market Size by Type
6.1.1 US & Canada Pharma Sustained Release Excipient Sales by Type (2018-2029)
6.1.2 US & Canada Pharma Sustained Release Excipient Revenue by Type (2018-2029)
6.2 US & Canada Pharma Sustained Release Excipient Market Size by Application
6.2.1 US & Canada Pharma Sustained Release Excipient Sales by Application (2018-2029)
6.2.2 US & Canada Pharma Sustained Release Excipient Revenue by Application (2018-2029)
6.3 US & Canada Pharma Sustained Release Excipient Market Size by Country
6.3.1 US & Canada Pharma Sustained Release Excipient Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Pharma Sustained Release Excipient Sales by Country (2018-2029)
6.3.3 US & Canada Pharma Sustained Release Excipient Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pharma Sustained Release Excipient Market Size by Type
7.1.1 Europe Pharma Sustained Release Excipient Sales by Type (2018-2029)
7.1.2 Europe Pharma Sustained Release Excipient Revenue by Type (2018-2029)
7.2 Europe Pharma Sustained Release Excipient Market Size by Application
7.2.1 Europe Pharma Sustained Release Excipient Sales by Application (2018-2029)
7.2.2 Europe Pharma Sustained Release Excipient Revenue by Application (2018-2029)
7.3 Europe Pharma Sustained Release Excipient Market Size by Country
7.3.1 Europe Pharma Sustained Release Excipient Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Pharma Sustained Release Excipient Sales by Country (2018-2029)
7.3.3 Europe Pharma Sustained Release Excipient Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pharma Sustained Release Excipient Market Size
8.1.1 China Pharma Sustained Release Excipient Sales (2018-2029)
8.1.2 China Pharma Sustained Release Excipient Revenue (2018-2029)
8.2 China Pharma Sustained Release Excipient Market Size by Application
8.2.1 China Pharma Sustained Release Excipient Sales by Application (2018-2029)
8.2.2 China Pharma Sustained Release Excipient Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Pharma Sustained Release Excipient Market Size by Type
9.1.1 Asia Pharma Sustained Release Excipient Sales by Type (2018-2029)
9.1.2 Asia Pharma Sustained Release Excipient Revenue by Type (2018-2029)
9.2 Asia Pharma Sustained Release Excipient Market Size by Application
9.2.1 Asia Pharma Sustained Release Excipient Sales by Application (2018-2029)
9.2.2 Asia Pharma Sustained Release Excipient Revenue by Application (2018-2029)
9.3 Asia Pharma Sustained Release Excipient Sales by Region
9.3.1 Asia Pharma Sustained Release Excipient Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Pharma Sustained Release Excipient Revenue by Region (2018-2029)
9.3.3 Asia Pharma Sustained Release Excipient Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pharma Sustained Release Excipient Market Size by Type
10.1.1 Middle East, Africa and Latin America Pharma Sustained Release Excipient Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Pharma Sustained Release Excipient Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Pharma Sustained Release Excipient Market Size by Application
10.2.1 Middle East, Africa and Latin America Pharma Sustained Release Excipient Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Pharma Sustained Release Excipient Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Pharma Sustained Release Excipient Sales by Country
10.3.1 Middle East, Africa and Latin America Pharma Sustained Release Excipient Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Pharma Sustained Release Excipient Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Pharma Sustained Release Excipient Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Teva Pharmaceutical Industries
11.1.1 Teva Pharmaceutical Industries Company Information
11.1.2 Teva Pharmaceutical Industries Overview
11.1.3 Teva Pharmaceutical Industries Pharma Sustained Release Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Teva Pharmaceutical Industries Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Pharmaceutical Industries Recent Developments
11.2 Mylan N.V.
11.2.1 Mylan N.V. Company Information
11.2.2 Mylan N.V. Overview
11.2.3 Mylan N.V. Pharma Sustained Release Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Mylan N.V. Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Mylan N.V. Recent Developments
11.3 Valeant Pharmaceuticals International
11.3.1 Valeant Pharmaceuticals International Company Information
11.3.2 Valeant Pharmaceuticals International Overview
11.3.3 Valeant Pharmaceuticals International Pharma Sustained Release Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Valeant Pharmaceuticals International Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Valeant Pharmaceuticals International Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Pharma Sustained Release Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Pfizer Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Sun Pharmaceutical Industries
11.5.1 Sun Pharmaceutical Industries Company Information
11.5.2 Sun Pharmaceutical Industries Overview
11.5.3 Sun Pharmaceutical Industries Pharma Sustained Release Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Sun Pharmaceutical Industries Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sun Pharmaceutical Industries Recent Developments
11.6 Novartis AG
11.6.1 Novartis AG Company Information
11.6.2 Novartis AG Overview
11.6.3 Novartis AG Pharma Sustained Release Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Novartis AG Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis AG Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Overview
11.7.3 AstraZeneca Pharma Sustained Release Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 AstraZeneca Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 AstraZeneca Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Information
11.8.2 GlaxoSmithKline Overview
11.8.3 GlaxoSmithKline Pharma Sustained Release Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 GlaxoSmithKline Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GlaxoSmithKline Recent Developments
11.9 Allergan
11.9.1 Allergan Company Information
11.9.2 Allergan Overview
11.9.3 Allergan Pharma Sustained Release Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Allergan Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Allergan Recent Developments
11.10 Janssen Pharmaceuticals
11.10.1 Janssen Pharmaceuticals Company Information
11.10.2 Janssen Pharmaceuticals Overview
11.10.3 Janssen Pharmaceuticals Pharma Sustained Release Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Janssen Pharmaceuticals Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Janssen Pharmaceuticals Recent Developments
11.11 Mayne Pharma Group
11.11.1 Mayne Pharma Group Company Information
11.11.2 Mayne Pharma Group Overview
11.11.3 Mayne Pharma Group Pharma Sustained Release Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Mayne Pharma Group Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Mayne Pharma Group Recent Developments
11.12 BASF
11.12.1 BASF Company Information
11.12.2 BASF Overview
11.12.3 BASF Pharma Sustained Release Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 BASF Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 BASF Recent Developments
11.13 International Flavors & Fragrances
11.13.1 International Flavors & Fragrances Company Information
11.13.2 International Flavors & Fragrances Overview
11.13.3 International Flavors & Fragrances Pharma Sustained Release Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 International Flavors & Fragrances Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 International Flavors & Fragrances Recent Developments
11.14 Ashland Global
11.14.1 Ashland Global Company Information
11.14.2 Ashland Global Overview
11.14.3 Ashland Global Pharma Sustained Release Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Ashland Global Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Ashland Global Recent Developments
11.15 Evonik Industries
11.15.1 Evonik Industries Company Information
11.15.2 Evonik Industries Overview
11.15.3 Evonik Industries Pharma Sustained Release Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Evonik Industries Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Evonik Industries Recent Developments
11.16 Croda International
11.16.1 Croda International Company Information
11.16.2 Croda International Overview
11.16.3 Croda International Pharma Sustained Release Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Croda International Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Croda International Recent Developments
11.17 Gattefosse
11.17.1 Gattefosse Company Information
11.17.2 Gattefosse Overview
11.17.3 Gattefosse Pharma Sustained Release Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Gattefosse Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Gattefosse Recent Developments
11.18 Merck KGaA
11.18.1 Merck KGaA Company Information
11.18.2 Merck KGaA Overview
11.18.3 Merck KGaA Pharma Sustained Release Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Merck KGaA Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Merck KGaA Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pharma Sustained Release Excipient Industry Chain Analysis
12.2 Pharma Sustained Release Excipient Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pharma Sustained Release Excipient Production Mode & Process
12.4 Pharma Sustained Release Excipient Sales and Marketing
12.4.1 Pharma Sustained Release Excipient Sales Channels
12.4.2 Pharma Sustained Release Excipient Distributors
12.5 Pharma Sustained Release Excipient Customers
13 Market Dynamics
13.1 Pharma Sustained Release Excipient Industry Trends
13.2 Pharma Sustained Release Excipient Market Drivers
13.3 Pharma Sustained Release Excipient Market Challenges
13.4 Pharma Sustained Release Excipient Market Restraints
14 Key Findings in The Global Pharma Sustained Release Excipient Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Pharma Sustained Release Excipient Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Gelatin
Table 3. Major Manufacturers of Polymers
Table 4. Major Manufacturers of Minerals
Table 5. Major Manufacturers of Sugars
Table 6. Major Manufacturers of Chitosan
Table 7. Global Pharma Sustained Release Excipient Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Pharma Sustained Release Excipient Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Pharma Sustained Release Excipient Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Pharma Sustained Release Excipient Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Pharma Sustained Release Excipient Revenue Market Share by Region (2018-2024)
Table 12. Global Pharma Sustained Release Excipient Revenue Market Share by Region (2024-2029)
Table 13. Global Pharma Sustained Release Excipient Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Pharma Sustained Release Excipient Sales by Region (2018-2024) & (Kiloton)
Table 15. Global Pharma Sustained Release Excipient Sales by Region (2024-2029) & (Kiloton)
Table 16. Global Pharma Sustained Release Excipient Sales Market Share by Region (2018-2024)
Table 17. Global Pharma Sustained Release Excipient Sales Market Share by Region (2024-2029)
Table 18. Global Pharma Sustained Release Excipient Sales by Manufacturers (2018-2024) & (Kiloton)
Table 19. Global Pharma Sustained Release Excipient Sales Share by Manufacturers (2018-2024)
Table 20. Global Pharma Sustained Release Excipient Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Pharma Sustained Release Excipient Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of Pharma Sustained Release Excipient, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. Pharma Sustained Release Excipient Price by Manufacturers 2018-2024 (US$/Ton)
Table 24. Global Pharma Sustained Release Excipient Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Pharma Sustained Release Excipient by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Sustained Release Excipient as of 2022)
Table 26. Global Key Manufacturers of Pharma Sustained Release Excipient, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Pharma Sustained Release Excipient, Product Offered and Application
Table 28. Global Key Manufacturers of Pharma Sustained Release Excipient, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Pharma Sustained Release Excipient Sales by Type (2018-2024) & (Kiloton)
Table 31. Global Pharma Sustained Release Excipient Sales by Type (2024-2029) & (Kiloton)
Table 32. Global Pharma Sustained Release Excipient Sales Share by Type (2018-2024)
Table 33. Global Pharma Sustained Release Excipient Sales Share by Type (2024-2029)
Table 34. Global Pharma Sustained Release Excipient Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Pharma Sustained Release Excipient Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Pharma Sustained Release Excipient Revenue Share by Type (2018-2024)
Table 37. Global Pharma Sustained Release Excipient Revenue Share by Type (2024-2029)
Table 38. Pharma Sustained Release Excipient Price by Type (2018-2024) & (US$/Ton)
Table 39. Global Pharma Sustained Release Excipient Price Forecast by Type (2024-2029) & (US$/Ton)
Table 40. Global Pharma Sustained Release Excipient Sales by Application (2018-2024) & (Kiloton)
Table 41. Global Pharma Sustained Release Excipient Sales by Application (2024-2029) & (Kiloton)
Table 42. Global Pharma Sustained Release Excipient Sales Share by Application (2018-2024)
Table 43. Global Pharma Sustained Release Excipient Sales Share by Application (2024-2029)
Table 44. Global Pharma Sustained Release Excipient Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Pharma Sustained Release Excipient Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Pharma Sustained Release Excipient Revenue Share by Application (2018-2024)
Table 47. Global Pharma Sustained Release Excipient Revenue Share by Application (2024-2029)
Table 48. Pharma Sustained Release Excipient Price by Application (2018-2024) & (US$/Ton)
Table 49. Global Pharma Sustained Release Excipient Price Forecast by Application (2024-2029) & (US$/Ton)
Table 50. US & Canada Pharma Sustained Release Excipient Sales by Type (2018-2024) & (Kiloton)
Table 51. US & Canada Pharma Sustained Release Excipient Sales by Type (2024-2029) & (Kiloton)
Table 52. US & Canada Pharma Sustained Release Excipient Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada Pharma Sustained Release Excipient Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Pharma Sustained Release Excipient Sales by Application (2018-2024) & (Kiloton)
Table 55. US & Canada Pharma Sustained Release Excipient Sales by Application (2024-2029) & (Kiloton)
Table 56. US & Canada Pharma Sustained Release Excipient Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada Pharma Sustained Release Excipient Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Pharma Sustained Release Excipient Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Pharma Sustained Release Excipient Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada Pharma Sustained Release Excipient Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Pharma Sustained Release Excipient Sales by Country (2018-2024) & (Kiloton)
Table 62. US & Canada Pharma Sustained Release Excipient Sales by Country (2024-2029) & (Kiloton)
Table 63. Europe Pharma Sustained Release Excipient Sales by Type (2018-2024) & (Kiloton)
Table 64. Europe Pharma Sustained Release Excipient Sales by Type (2024-2029) & (Kiloton)
Table 65. Europe Pharma Sustained Release Excipient Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe Pharma Sustained Release Excipient Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Pharma Sustained Release Excipient Sales by Application (2018-2024) & (Kiloton)
Table 68. Europe Pharma Sustained Release Excipient Sales by Application (2024-2029) & (Kiloton)
Table 69. Europe Pharma Sustained Release Excipient Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe Pharma Sustained Release Excipient Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Pharma Sustained Release Excipient Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Pharma Sustained Release Excipient Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe Pharma Sustained Release Excipient Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Pharma Sustained Release Excipient Sales by Country (2018-2024) & (Kiloton)
Table 75. Europe Pharma Sustained Release Excipient Sales by Country (2024-2029) & (Kiloton)
Table 76. China Pharma Sustained Release Excipient Sales by Type (2018-2024) & (Kiloton)
Table 77. China Pharma Sustained Release Excipient Sales by Type (2024-2029) & (Kiloton)
Table 78. China Pharma Sustained Release Excipient Revenue by Type (2018-2024) & (US$ Million)
Table 79. China Pharma Sustained Release Excipient Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Pharma Sustained Release Excipient Sales by Application (2018-2024) & (Kiloton)
Table 81. China Pharma Sustained Release Excipient Sales by Application (2024-2029) & (Kiloton)
Table 82. China Pharma Sustained Release Excipient Revenue by Application (2018-2024) & (US$ Million)
Table 83. China Pharma Sustained Release Excipient Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Pharma Sustained Release Excipient Sales by Type (2018-2024) & (Kiloton)
Table 85. Asia Pharma Sustained Release Excipient Sales by Type (2024-2029) & (Kiloton)
Table 86. Asia Pharma Sustained Release Excipient Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia Pharma Sustained Release Excipient Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Pharma Sustained Release Excipient Sales by Application (2018-2024) & (Kiloton)
Table 89. Asia Pharma Sustained Release Excipient Sales by Application (2024-2029) & (Kiloton)
Table 90. Asia Pharma Sustained Release Excipient Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia Pharma Sustained Release Excipient Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Pharma Sustained Release Excipient Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Pharma Sustained Release Excipient Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia Pharma Sustained Release Excipient Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Pharma Sustained Release Excipient Sales by Region (2018-2024) & (Kiloton)
Table 96. Asia Pharma Sustained Release Excipient Sales by Region (2024-2029) & (Kiloton)
Table 97. Middle East, Africa and Latin America Pharma Sustained Release Excipient Sales by Type (2018-2024) & (Kiloton)
Table 98. Middle East, Africa and Latin America Pharma Sustained Release Excipient Sales by Type (2024-2029) & (Kiloton)
Table 99. Middle East, Africa and Latin America Pharma Sustained Release Excipient Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Pharma Sustained Release Excipient Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Pharma Sustained Release Excipient Sales by Application (2018-2024) & (Kiloton)
Table 102. Middle East, Africa and Latin America Pharma Sustained Release Excipient Sales by Application (2024-2029) & (Kiloton)
Table 103. Middle East, Africa and Latin America Pharma Sustained Release Excipient Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Pharma Sustained Release Excipient Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Pharma Sustained Release Excipient Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Pharma Sustained Release Excipient Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Pharma Sustained Release Excipient Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Pharma Sustained Release Excipient Sales by Country (2018-2024) & (Kiloton)
Table 109. Middle East, Africa and Latin America Pharma Sustained Release Excipient Sales by Country (2024-2029) & (Kiloton)
Table 110. Teva Pharmaceutical Industries Company Information
Table 111. Teva Pharmaceutical Industries Description and Major Businesses
Table 112. Teva Pharmaceutical Industries Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 113. Teva Pharmaceutical Industries Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Teva Pharmaceutical Industries Recent Developments
Table 115. Mylan N.V. Company Information
Table 116. Mylan N.V. Description and Major Businesses
Table 117. Mylan N.V. Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 118. Mylan N.V. Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Mylan N.V. Recent Developments
Table 120. Valeant Pharmaceuticals International Company Information
Table 121. Valeant Pharmaceuticals International Description and Major Businesses
Table 122. Valeant Pharmaceuticals International Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 123. Valeant Pharmaceuticals International Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Valeant Pharmaceuticals International Recent Developments
Table 125. Pfizer Company Information
Table 126. Pfizer Description and Major Businesses
Table 127. Pfizer Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 128. Pfizer Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Pfizer Recent Developments
Table 130. Sun Pharmaceutical Industries Company Information
Table 131. Sun Pharmaceutical Industries Description and Major Businesses
Table 132. Sun Pharmaceutical Industries Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 133. Sun Pharmaceutical Industries Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Sun Pharmaceutical Industries Recent Developments
Table 135. Novartis AG Company Information
Table 136. Novartis AG Description and Major Businesses
Table 137. Novartis AG Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 138. Novartis AG Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Novartis AG Recent Developments
Table 140. AstraZeneca Company Information
Table 141. AstraZeneca Description and Major Businesses
Table 142. AstraZeneca Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 143. AstraZeneca Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. AstraZeneca Recent Developments
Table 145. GlaxoSmithKline Company Information
Table 146. GlaxoSmithKline Description and Major Businesses
Table 147. GlaxoSmithKline Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 148. GlaxoSmithKline Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. GlaxoSmithKline Recent Developments
Table 150. Allergan Company Information
Table 151. Allergan Description and Major Businesses
Table 152. Allergan Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 153. Allergan Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Allergan Recent Developments
Table 155. Janssen Pharmaceuticals Company Information
Table 156. Janssen Pharmaceuticals Description and Major Businesses
Table 157. Janssen Pharmaceuticals Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 158. Janssen Pharmaceuticals Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Janssen Pharmaceuticals Recent Developments
Table 160. Mayne Pharma Group Company Information
Table 161. Mayne Pharma Group Description and Major Businesses
Table 162. Mayne Pharma Group Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 163. Mayne Pharma Group Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Mayne Pharma Group Recent Developments
Table 165. BASF Company Information
Table 166. BASF Description and Major Businesses
Table 167. BASF Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 168. BASF Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. BASF Recent Developments
Table 170. International Flavors & Fragrances Company Information
Table 171. International Flavors & Fragrances Description and Major Businesses
Table 172. International Flavors & Fragrances Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 173. International Flavors & Fragrances Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. International Flavors & Fragrances Recent Developments
Table 175. Ashland Global Company Information
Table 176. Ashland Global Description and Major Businesses
Table 177. Ashland Global Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 178. Ashland Global Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Ashland Global Recent Developments
Table 180. Evonik Industries Company Information
Table 181. Evonik Industries Description and Major Businesses
Table 182. Evonik Industries Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 183. Evonik Industries Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Evonik Industries Recent Developments
Table 185. Croda International Company Information
Table 186. Croda International Description and Major Businesses
Table 187. Croda International Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 188. Croda International Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Croda International Recent Developments
Table 190. Gattefosse Company Information
Table 191. Gattefosse Description and Major Businesses
Table 192. Gattefosse Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 193. Gattefosse Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 194. Gattefosse Recent Developments
Table 195. Merck KGaA Company Information
Table 196. Merck KGaA Description and Major Businesses
Table 197. Merck KGaA Pharma Sustained Release Excipient Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 198. Merck KGaA Pharma Sustained Release Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 199. Merck KGaA Recent Developments
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Pharma Sustained Release Excipient Distributors List
Table 203. Pharma Sustained Release Excipient Customers List
Table 204. Pharma Sustained Release Excipient Market Trends
Table 205. Pharma Sustained Release Excipient Market Drivers
Table 206. Pharma Sustained Release Excipient Market Challenges
Table 207. Pharma Sustained Release Excipient Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharma Sustained Release Excipient Product Picture
Figure 2. Global Pharma Sustained Release Excipient Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Pharma Sustained Release Excipient Market Share by Type in 2022 & 2029
Figure 4. Gelatin Product Picture
Figure 5. Polymers Product Picture
Figure 6. Minerals Product Picture
Figure 7. Sugars Product Picture
Figure 8. Chitosan Product Picture
Figure 9. Global Pharma Sustained Release Excipient Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Pharma Sustained Release Excipient Market Share by Application in 2022 & 2029
Figure 11. Pharmaceutical
Figure 12. Health Care
Figure 13. Others
Figure 14. Pharma Sustained Release Excipient Report Years Considered
Figure 15. Global Pharma Sustained Release Excipient Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Pharma Sustained Release Excipient Revenue 2018-2029 (US$ Million)
Figure 17. Global Pharma Sustained Release Excipient Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Pharma Sustained Release Excipient Revenue Market Share by Region (2018-2029)
Figure 19. Global Pharma Sustained Release Excipient Sales 2018-2029 ((Kiloton)
Figure 20. Global Pharma Sustained Release Excipient Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Pharma Sustained Release Excipient Sales YoY (2018-2029) & (Kiloton)
Figure 22. US & Canada Pharma Sustained Release Excipient Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Pharma Sustained Release Excipient Sales YoY (2018-2029) & (Kiloton)
Figure 24. Europe Pharma Sustained Release Excipient Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Pharma Sustained Release Excipient Sales YoY (2018-2029) & (Kiloton)
Figure 26. China Pharma Sustained Release Excipient Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Pharma Sustained Release Excipient Sales YoY (2018-2029) & (Kiloton)
Figure 28. Asia (excluding China) Pharma Sustained Release Excipient Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Pharma Sustained Release Excipient Sales YoY (2018-2029) & (Kiloton)
Figure 30. Middle East, Africa and Latin America Pharma Sustained Release Excipient Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Pharma Sustained Release Excipient Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Pharma Sustained Release Excipient in the World: Market Share by Pharma Sustained Release Excipient Revenue in 2022
Figure 33. Global Pharma Sustained Release Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Pharma Sustained Release Excipient Sales Market Share by Type (2018-2029)
Figure 35. Global Pharma Sustained Release Excipient Revenue Market Share by Type (2018-2029)
Figure 36. Global Pharma Sustained Release Excipient Sales Market Share by Application (2018-2029)
Figure 37. Global Pharma Sustained Release Excipient Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Pharma Sustained Release Excipient Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Pharma Sustained Release Excipient Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Pharma Sustained Release Excipient Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Pharma Sustained Release Excipient Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Pharma Sustained Release Excipient Revenue Share by Country (2018-2029)
Figure 43. US & Canada Pharma Sustained Release Excipient Sales Share by Country (2018-2029)
Figure 44. U.S. Pharma Sustained Release Excipient Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Pharma Sustained Release Excipient Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Pharma Sustained Release Excipient Sales Market Share by Type (2018-2029)
Figure 47. Europe Pharma Sustained Release Excipient Revenue Market Share by Type (2018-2029)
Figure 48. Europe Pharma Sustained Release Excipient Sales Market Share by Application (2018-2029)
Figure 49. Europe Pharma Sustained Release Excipient Revenue Market Share by Application (2018-2029)
Figure 50. Europe Pharma Sustained Release Excipient Revenue Share by Country (2018-2029)
Figure 51. Europe Pharma Sustained Release Excipient Sales Share by Country (2018-2029)
Figure 52. Germany Pharma Sustained Release Excipient Revenue (2018-2029) & (US$ Million)
Figure 53. France Pharma Sustained Release Excipient Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Pharma Sustained Release Excipient Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Pharma Sustained Release Excipient Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Pharma Sustained Release Excipient Revenue (2018-2029) & (US$ Million)
Figure 57. China Pharma Sustained Release Excipient Sales Market Share by Type (2018-2029)
Figure 58. China Pharma Sustained Release Excipient Revenue Market Share by Type (2018-2029)
Figure 59. China Pharma Sustained Release Excipient Sales Market Share by Application (2018-2029)
Figure 60. China Pharma Sustained Release Excipient Revenue Market Share by Application (2018-2029)
Figure 61. Asia Pharma Sustained Release Excipient Sales Market Share by Type (2018-2029)
Figure 62. Asia Pharma Sustained Release Excipient Revenue Market Share by Type (2018-2029)
Figure 63. Asia Pharma Sustained Release Excipient Sales Market Share by Application (2018-2029)
Figure 64. Asia Pharma Sustained Release Excipient Revenue Market Share by Application (2018-2029)
Figure 65. Asia Pharma Sustained Release Excipient Revenue Share by Region (2018-2029)
Figure 66. Asia Pharma Sustained Release Excipient Sales Share by Region (2018-2029)
Figure 67. Japan Pharma Sustained Release Excipient Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Pharma Sustained Release Excipient Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Pharma Sustained Release Excipient Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Pharma Sustained Release Excipient Revenue (2018-2029) & (US$ Million)
Figure 71. India Pharma Sustained Release Excipient Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Pharma Sustained Release Excipient Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Pharma Sustained Release Excipient Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Pharma Sustained Release Excipient Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Pharma Sustained Release Excipient Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Pharma Sustained Release Excipient Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Pharma Sustained Release Excipient Sales Share by Country (2018-2029)
Figure 78. Brazil Pharma Sustained Release Excipient Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Pharma Sustained Release Excipient Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey Pharma Sustained Release Excipient Revenue (2018-2029) & (US$ Million)
Figure 81. Israel Pharma Sustained Release Excipient Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries Pharma Sustained Release Excipient Revenue (2018-2029) & (US$ Million)
Figure 83. Pharma Sustained Release Excipient Value Chain
Figure 84. Pharma Sustained Release Excipient Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed